D
DelRicht Research | Jaggu Health - Vienna, VA
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
CK-4021586
Parent organization
This site is a part of DelRicht Research
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
1 of 1 total trial
This is a Phase 2 dose-finding study in adult participants with symptomatic HFpEF.
Enrolling
Symptomatic Heart Failure With Preserved Ejection Fraction (HFpEF)
Drug: CK-4021586 (150 mg, 300 mg, 450 mg, and 600 mg)
Drug: Placebo to match CK-4021586
Trial sponsors
Clinical trials
Research sites
Resources
Legal
© Copyright 2025 Veeva Systems